← SynDRA
XMD-1150
SynDRA canonical compound SYN0087416 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | LRRK2 |
|---|
| Mechanism of action | Leucine rich repeat kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Leucine rich repeat kinase inhibitor
- LRRK2 INHIBITOR
Cross-references
Synonyms
- LRRK2-IN-1
- LRRK2-IN1
- XMD11-50
- Lrrk2-IN-1
- LRRK2IN1
- CHEBI:78413
- RefChem:154163
- LRRK-2IN1
- BDBM50379529
- C31H38N8O3
- 4K4
- MFCD22683805
- LRRK2-TN-1
- MLS003230940
- LRRK2-IN-1?
- SCHEMBL616761
- GTPL9396
- orb1305906
- SCHEMBL29389108
- SCHEMBL29596956
- EX-A644
- BDBM482157
- GLXC-02871
- HMS3265O17
- HMS3265O18
- HMS3265P17
- HMS3265P18
- s7584
- AKOS024458067
- CCG-270098
- CS-0246
- EBC-220177
- SB18523
- NCGC00346807-01
- NCGC00346807-03
- NCGC00346807-04
- AC-35378
- AS-56177
- DA-75116
Look up XMD-1150 in the interactive SynDRA portal →